5,163
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

COPD Patients’ Experience of Long-Term Domestic Oxygen-Enriched Nasal High Flow Treatment: A Qualitative Study

ORCID Icon, ORCID Icon & ORCID Icon
Pages 175-183 | Received 17 Jan 2020, Accepted 26 Feb 2020, Published online: 17 Mar 2020

References

  • Miravitlles M, Worth H, Soler Cataluña JJ, et al. Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study. Respir Res. 2014;15(1):1–13. doi:10.1186/s12931-014-0122-1.
  • Miravitlles M, Ribera A. Understanding the impact of symptoms on the burden of COPD. Respir Res. 2017;18(1):1–11. doi:10.1186/s12931-017-0548-3.
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) [Internet]. 2019 [cited 2019 Oct 31]. Available from: http://www.goldcopd.org/.
  • Williams V, Bruto A, Ellis-Hill C, et al. What really matters to patients living with chronic obstructive pulmonary disease? An exploratory study. Chron Respir Dis. 2007;4(2):77–85. doi:10.1177/1479972307078482.
  • Zamzam MA, Azab NY, El Wahsh RA, et al. Quality of life in COPD patients. Egypt J Chest Dis Tuberc. 2012;61(4):281–289. doi:10.1016/j.ejcdt.2012.08.012.
  • Budweiser S, Hitzl AP, Jörres RA, et al. Health-related quality of life and long-term prognosis in chronic hypercapnic respiratory failure: a prospective survival analysis. Respir Res. 2007;8(1):9. doi:10.1186/1465-9921-8-92.
  • Pinnock H, Kendall M, Murray SA, et al. Living and dying with severe chronic obstructive pulmonary disease: multi-perspective longitudinal qualitative study. BMJ 2011;342(1):d142–d142. doi:10.1136/bmj.d142.
  • Wedzicha J, Seemungal T. COPD exacerbations: defining their cause and prevention. Lancet 2007;370(9589):786–796. doi:10.1016/S0140-6736(07)61382-8.
  • Budweiser S, Jörres RA, Pfeifer M. Treatment of respiratory failure in COPD. Int J COPD. 2008;3(4):605–618. doi:10.2147/COPD.S3814.
  • Ringbaek TJ, Lange P. Trends in long-term oxygen therapy for COPD in Denmark from 2001 to 2010. Respir Med. 2014;108(3):511–516. doi:10.1016/j.rmed.2013.10.025.
  • Report of the Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981;317(8222):681–686.
  • Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med 1980;93:391–398.
  • Katsenos S, Constantopoulos SH. Long-term oxygen therapy in COPD: factors affecting and ways of improving patient compliance. Pulm Med. 2011;2011:1–8. doi:10.1155/2011/325362.
  • Kampelmacher MJ, Van Kesteren RG, Alsbach GPJ, et al. Characteristics and complaints of patients prescribed long-term oxygen therapy in The Netherlands. Respir Med. 1998;92(1):70–75. doi:10.1016/S0954-6111(98)90035-X.
  • Spencer TR, Barcomb TF. New technologies in COPD management. Curr Emerg Hosp Med Rep. 2014;2(3):143–150. doi:10.1007/s40138-014-0051-9.
  • Storgaard LH, Hockey H, Laursen BS, et al. Long-term effects of oxygen-enriched nasal high flow treatment in COPD with chronic hypoxemic respiratory failure. COPD. 2018;13:1195–1205. doi:10.2147/COPD.S159666.
  • Bosworth H. Improving patient treatment adherence: a clinician’s guide. Bosworth H, editor. Vol. 53. New York (NY): Springer; 2010. p. 160.
  • World Health Organization. Adherence to long-term therapies: evidence for action. Vol. 2. Geneva (Switzerland): WHO; 2003.
  • Kvale S, Brinkmann S. Interview: Det kvalitative forskningsinterview som håndvaerk. 3rd ed. Copenhagen (Denmark): Hans Reitzels Forlag; 2015.
  • Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Heal Care. 2007;19(6):349–357. doi:10.1093/intqhc/mzm042.
  • Price D, Small M, Milligan G, et al. Impact of night-time symptoms in COPD : a real-world study in five European countries. Int J Chron Obstruct Pulmon Dis. 2013;8:595–603.
  • Omachi T, Blanc P, Claman D, et al. Disturbed sleep among COPD patients is longitudinally associated with mortality and adverse COPD outcomes. Sleep Med. 2012;13(5):476–483. doi:10.1016/j.sleep.2011.12.007.
  • Stephenson JJ, Cai Q, Mocarski M, et al. Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:577–586. doi:10.2147/COPD.S76157.
  • Deslee G, Burgel PR, Escamilla R, et al. Impact of current cough on health-related quality of life in patients with COPD. Int J COPD. 2016;11(1):2091–2097. doi:10.2147/COPD.S106883.
  • Peruzza S, Sergi G, Vianello A, et al. Chronic obstructive pulmonary disease (COPD) in elderly subjects: impact on functional status and quality of life. Respir Med. 2003;97(6):612–617. doi:10.1053/rmed.2003.1488.
  • Monteagudo M, Rodríguez-Blanco T, Llagostera M, et al. Factors associated with changes in quality of life of COPD patients: a prospective study in primary care. Respir Med. 2013;107(10):1589–1597. doi:10.1016/j.rmed.2013.05.009.
  • Cook N, Gey J, Oezel B, et al. Impact of cough and mucus on COPD patients: primary insights from an exploratory study with an Online Patient Community. COPD. 2019;14:1365–1376. doi:10.2147/COPD.S202580.
  • Van Buul AR, Kasteleyn MJ, Chavannes NH, et al. Association between morning symptoms and physical activity in COPD: a systematic review. Eur Respir Rev. 2017;26(143):160033. doi:10.1183/16000617.0033-2016.
  • Kessler R, Partridge MR, Miravitlles M, et al. Symptom variability in patients with severe COPD: a pan-European crosssectional study. Eur Respir J. 2011;37(2):264–272. doi:10.1183/09031936.00051110.
  • Roche N, Small M, Broomfield S, et al. Real world COPD: association of morning symptoms with clinical and patient reported outcomes. COPD 2013;10(6):679–686. doi:10.3109/15412555.2013.844784.
  • Partridge MR, Karlsson N, Small IR. Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey. Curr Med Res Opin. 2009;25(8):2043–2048. doi:10.1185/03007990903103006.
  • Gardiner C, Gott M, Payne S, et al. Exploring the care needs of patients with advanced COPD: an overview of the literature. Respir Med. 2010;104(2):159–165. doi:10.1016/j.rmed.2009.09.007.
  • Odencrants S, Ehnfors M, Grobe SJ. Living with chronic obstructive pulmonary disease: part I. Struggling with meal-related situations: experiences among persons with COPD. Scand J Caring Sci. 2005;19(3):230–239. doi:10.1111/j.1471-6712.2005.00345.x.
  • Holden RJ, Karsh B-T. The technology acceptance model: its past and its future in health care. J Biomed Inform. 2010;43(1):159–172. doi:10.1016/j.jbi.2009.07.002.
  • Legris P, Ingham J, Collerette P. Why do people use information technology? A critical review of the technology acceptance model. Inf Manag. 2003;40(3):191–204. doi:10.1016/S0378-7206(01)00143-4.
  • Ding A, Patel JP, Auyeung V. Attitudes and beliefs that affect adherence to provider-based complementary and alternative medicine: a systematic review. Eur J Integr Med. 2018;17:92–101. doi:10.1016/j.eujim.2017.12.002.
  • Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47(6):555–567. doi:10.1016/S0022-3999(99)00057-4.
  • de Veer A, Fleuren M, Bekkema N, et al. Successful implementation of new technologies in nursing care: a questionnaire survey of nurse-users. BMC Med Inform Decis Mak. 2011;11(1):1–12. doi:10.1186/1472-6947-11-67.
  • Strudwick G, McGillis Hall L. Nurse acceptance of electronic health record technology: a literature review. J Res Nurs. 2015;20(7):596–607. doi:10.1177/1744987115615658.